A study finds most children with enterovirus meningitis have favorable long-term outcomes, with only 8.9% experiencing adverse sequelae. Meanwhile, global data shows 259,000 meningitis deaths in 2023, with children under 5 accounting for over one-third of fatalities. Non-polio enteroviruses were the leading cause of meningitis cases worldwide.
The FDA approved Zycubo (copper histidinate) on January 13, 2026, as the first treatment for Menkes disease in pediatric patients, following resolution of manufacturing compliance concerns that led to an initial rejection in September 2025.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05391594 |
Effect of Trunk Support on Academic Engagement of Children With Severe Disability |
COMPLETED | NA |
| NCT04894799 |
Vestibular Stimulation and Neurodevelopmental Technique on Hypotonic Cerebral Palsy While Controlling the Gender |
COMPLETED | NA |
| NCT04846400 |
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia |
COMPLETED | NA |
| NCT03852004 |
Osteopathic Treatment on Motor Development of Hypotonic Infants. |
RECRUITING | NA |
| NCT03548779 |
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 |
COMPLETED | NA |
| NCT03492060 |
Longitudinal Study of Neurogenetic Disorders |
RECRUITING |
